心型脂肪酸结合蛋白在急性心肌梗死患者早期诊断中的应用价值

doi:10.16150/j.1671-2870.2016.06.008

摘要/Abstract

摘要： 目的: 探讨血清心型脂肪酸结合蛋白（heart-type fatty acid-binding protein,H-FABP）在急性心肌梗死（acute myocardial infarction,AMI）早期诊断中的应用价值。方法: 应用乳胶凝集法检测105例因胸痛疑似AMI就诊患者的血清H-FABP,同时测定患者血清中肌酸激酶同工酶MB（creatine kinase isoenzyme MB,CK-MB）、肌红蛋白（myoglobin, MYO）和心肌钙蛋白I（cardiac troponinc I,cTnI）。根据最终的临床诊断将患者分为AMI组和非AMI组（对照组）,并对2组检测结果的阳性率、诊断效率等进行分析比较。结果: 105例疑似AMI患者中,最终诊断为AMI患者45例,其余60例排除AMI诊断作为对照组。AMI组的H-FABP、cTnI、MYO、CK-MB平均水平及阳性率分别为（49.32±10.29） ng/mL、84.4%,（1.62±0.76） ng/mL、44.4%,（156.14±54.23） ng/mL、82.2%,（13.01±6.08） ng/mL、42.2%,均高于对照组（P<0.05）;AMI组中H-FABP阳性率与MYO阳性率间无统计学差异（P>0.05）,但明显高于cTnI及CK-MB的阳性率（P<0.05）。H-FABP与CK-MB诊断AMI的特异度相似（P>0.05）,但低于cTnI（P<0.05）,高于MYO（P<0.05）。H-FABP与cTnI的阳性预测值相似（P>0.05）,均高于MYO、CK-MB（P<0.05）。在阴性预测值方面,H-FABP与MYO相似（P>0.05）,明显高于cTnI和CK-MB（P<0.05）。4项指标检测结果进行组合分析,H-FABP+ cTnI、H-FABP+ CK-MB、H-FABP+ MYO、H-FABP+ cTnI+MYO、H-FABP+ cTnI+CK-MB、H-FABP+ cTnI+MYO+CK-MB诊断AMI的灵敏度均为100.0%,特异度分别为82.0%、72.0%、61.2%、59.3%、68.1%和56.5%。结论: H-FABP在AMI早期诊断中具有较好的灵敏度和特异度,与cTnI联合检测,可显著提高AMI早期诊断效能。

关键词: 心型脂肪酸结合蛋白, 心肌钙蛋白I, 肌酸激酶同工酶MB, 肌红蛋白, 急性心肌梗死

Abstract: Objective: To investigate the clinical value of heart-type fatty acid-binding protein (H-FABP) in early diagnosis of acute myocardial infarction (AMI). Methods: Serum concentration of H-FABP was measured with latex agglutination assay in 105 cases of suspected AMI because of chest pain. Cardiac troponin I (cTnI), myoglobin (MYO) and creatine kinase isoenzyme MB(CK-MB) were detected simultaneously. According to final clinical diagnosis, patients were divided into AMI group (n=45) and non-AMI group (control group, n=60). Related data between the two groups was compared. Results: The concentration and positive rate of H-FABP, cTnI, MYO and CK-MB were (49.32±10.29) ng/mL and 84.4%, (1.62±0.76) ng/mL and 44.4%, (156.14±54.23) ng/mL and 82.2%, (13.01±6.08) ng/mL and 42.2%, respectively, and all were higher in AMI group than those in control group (P<0.05). The difference in positive rate between H-FABP and MYO in AMI group was not significant (P>0.05), however, the positive rate of H-FABP and MYO was significantly higher than cTnI and CK-MB (P<0.05). The specificity of H-FABP was similar to that of CK-MB (P>0.05), and both of them were lower than cTnI (P<0.05) and higher than MYO (P<0.05). The positive predictive value of H-FABP was equal to cTnI (P>0.05), and both of them were significantly higher than MYO and CK-MB (P<0.05). The negative predictive value between H-FABP and MYO was not significantly different (P>0.05), and both of them were significantly higher than cTnI and CK-MB (P<0.05). Combinedly, the sensitivity of H-FABP+ cTnI, H-FABP+ CK-MB, H-FABP+ MYO, H-FABP+ cTnI+MYO, H-FABP+ cTnI+CK-MB and H-FABP+ cTnI+MYO+CK-MB were all of 100.0%, and the specificity were 82.0%, 72.0%, 61.2%, 59.3%, 68.1% and 56.5%, respectively. Conclusions: H-FABP has a moderately high sensitivity and specificity for early diagnosis of AMI. Furthermore, H-FABP in combination with cTnI can significantly improve the efficacy in early diagnosis of AMI.

Key words: Heart-type fatty acid-binding protein, Cardiac troponin I, Creatine kinase isoenzyme MB, Myoglobin, Acute myocardial infarction

中图分类号:

R542.2⁺2

万颖蕾, 倪逸敏, 顾志冬. 心型脂肪酸结合蛋白在急性心肌梗死患者早期诊断中的应用价值[J]. 诊断学理论与实践, 2016, 15(06): 582-585.

WAN Yinglei, NI Yimin, GU Zhidong. Clinical value of heart-type fatty acid-binding protein in early diagnosis of acute myocardial infarction[J]. Journal of Diagnostics Concepts & Practice, 2016, 15(06): 582-585.

参考文献

[1] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会, 《中国循环杂志》编辑委员会. 急性心肌梗死诊断和治疗指南[J]. 中华心血管病杂志,2001,29(12):705-720.
[2] 张志华, 徐崇利. 不同年龄段急性心肌梗死患者发病时间特征及预后分析[J]. 安徽医学,2016,37(2):203-205.
[3] 潘柏申. 心肌损伤标志物的研究进展与心肌梗死诊断标准的修订[J]. 临床检验杂志,2002,20(3):129-132.
[4] Azzazy HM, Pelsers MM, Christenson RH.Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications[J]. Clin Chem,2006,52(1):19-29.
[5] Nakata T, Hashimoto A, Hase M, et al.Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome[J]. Cardiology,2003,99(2):96-104.
[6] 周晓茜,蔡英,于萍,等. 心型脂肪酸结合蛋白在急性心肌梗死早期诊断价值的研究[J]. 中国急救医学,2013, 33(3):212-215.
[7] 王亚蓉, 郭壮波, 黄丽萍. 三种心肌损伤标志物对早期急性心肌梗死的诊断价值[J]. 南方医科大学学报,2014,34(9):1347-1350.
[8] O'Donoghue M, de Lemos JA, Morrow DA, et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes[J]. Circulation,2006,114(6):550-557.
[9] Alhadi HA, Fox KA.Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein[J]. QJM,2004,97(4):187-198.
[10] Pyati AK, Devaranavadagi BB, Sajjannar SL, et al.Heart-type fatty acid-binding protein, in early detection of acute myocardial infarction: Comparison with CK-MB, troponin I and myoglobin[J]. Indian J Clin Biochem,2016,31(4):439-445.
[11] Kabekkodu SP, Mananje SR, Saya RP. A study on the role of heart type fatty acid binding protein in the diagnosis of acute myocardial infarction[J]. Clin Diagn Res,2016,10(1):OC07-OC10.
[12] Pyati AK, Devaranavadagi BB, Sajjannar SL, et al. Heart-type fatty acid binding protein: A better cardiac Biomarker than CK-MB and Myoglobin in the Early diagnosis of acute myocardial infarction[J]. J Clin Diagn Res,2015,9(10):BC08-BC11.
[13] Carroll C, Al Khalaf M, Stevens JW, et al.Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis[J]. Emerg Med J,2013,30(4):280-286.
[14] Lippi G, Mattiuzzi C, Cervellin G.Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction[J]. Clin Biochem,2013, 46(1-2):26-30.
[15] Young JM, Pickering JW, George PM, et al.Heart fatty acid binding protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction[J]. BMC Emerg Med,2016,16(1):34.
[16] 梁磊, 张彬, 李萍, 等. 急救干预对急性ST段抬高型心肌梗死预后的影响[J]. 内科理论与实践,2016,11(1):24-27.